 BLACKSBURG, Va., Sept. 01, 2021 GLOBE NEWSWIRE -- Landos Biopharma, Inc. NASDAQ: LABP, a late-clinical-stage biopharmaceutical company utilizing its LANCE Advanced A.I. platform to develop novel oral therapeutics for patients with autoimmune diseases, today announced that Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer of Landos will participate in two upcoming virtual investor conferences in September. 